Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on March 9, 2006

Arteriosclerosis, Thrombosis, and Vascular Biology. 2006
Published online before print March 9, 2006, doi: 10.1161/01.ATV.0000216282.58291.c6
A more recent version of this article appeared on June 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/6/1391    most recent
01.ATV.0000216282.58291.c6v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matuskova, J.
Right arrow Articles by Wagner, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matuskova, J.
Right arrow Articles by Wagner, D. D.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*FERRIC CHLORIDE
Related Collections
Right arrowRelated Article

Submitted on December 1, 2005
Accepted on February 22, 2006

Decreased Plasma Fibronectin Leads to Delayed Thrombus Growth in Injured Arterioles

Jana Matuskova ; Anil K. Chauhan ; Beatrice Cambien ; Sophie Astrof ; Vandana S. Dole ; Crystal L. Piffath ; Richard O. Hynes ; and Denisa D. Wagner *

From the CBR Institute for Biomedical Research (J.M., A.K.C., B.C., V.S.D., C.L.P., D.D.W.)and Department of Pathology (J.M., A.K.C., B.C., V.S.D., D.D.W.), Harvard Medical School, Boston; and Howard Hughes Medical Institute (S.A., R.O.H.), Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge.

* To whom correspondence should be addressed. E-mail: wagner{at}cbr.med.harvard.edu.

Objective--Plasma fibronectin (FN) is decreased in several clinical conditions. We were interested to study the thrombotic and hemostatic consequences of the decrease in plasma FN (pFN), the role of FN splice variants in thrombosis, and to examine whether pFN incorporates into thrombi in vivo.

Methods and Results--We compared the thrombotic response to a vessel injury in FN heterozygous (FN+/-) mice and corresponding FN+/+ mice. Although normal thrombosis in venules was observed, a decrease to half in the pFN concentration in FN+/- mice caused a delay in the appearance of thrombi in arterioles and consequently a delay in their occlusion. We were able to rescue the thrombotic defect in the FN+/- mice by infusion of rat pFN. Additionally, we could show intense incorporation of fluorescent pFN-coated microspheres into the developing thrombi. Moreover, we found that mice expressing FN without the EIIIA or EIIIB domains specific to cellular FN including platelet FN had no thrombotic defect.

Conclusions--Mice heterozygous for FN have a striking defect in thrombus initiation and growth in arterioles attributable to the decrease of pFN. Our study is an example of haploid insufficiency for FN, and it emphasizes the fundamental role of this plasma protein in thrombosis in the arterial system.


Key words: plasma fibronectin • arterial and venous injury • thrombus • fibronectin splice variants • intravital microscopy


Related Article:

Plasma Fibronectin Concentration: A Risk Factor for Arterial Thrombosis?
Deane F. Mosher
Arterioscler. Thromb. Vasc. Biol. 2006 26: 1193-1195. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. F. Mosher
Adding Complexity to Fibronectin-Platelet Interactions
Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 203 - 204.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. K. Chauhan, J. Kisucka, M. R. Cozzi, M. T. Walsh, F. A. Moretti, M. Battiston, M. Mazzucato, L. De Marco, F. E. Baralle, D. D. Wagner, et al.
Prothrombotic Effects of Fibronectin Isoforms Containing the EDA Domain
Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 296 - 301.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. J. Westrick, M. E. Winn, and D. T. Eitzman
Murine Models of Vascular Thrombosis
Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2079 - 2093.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. A. Moretti, A. K. Chauhan, A. Iaconcig, F. Porro, F. E. Baralle, and A. F. Muro
A Major Fraction of Fibronectin Present in the Extracellular Matrix of Tissues Is Plasma-derived
J. Biol. Chem., September 21, 2007; 282(38): 28057 - 28062.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. P. Jackson
The growing complexity of platelet aggregation
Blood, June 15, 2007; 109(12): 5087 - 5095.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. V. Denis and D. D. Wagner
Platelet Adhesion Receptors and Their Ligands in Mouse Models of Thrombosis
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 728 - 739.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. K. Chauhan, J. Kisucka, C. B. Lamb, W. Bergmeier, and D. D. Wagner
von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins
Blood, March 15, 2007; 109(6): 2424 - 2429.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. Bergmeier, C. L. Piffath, T. Goerge, S. M. Cifuni, Z. M. Ruggeri, J. Ware, and D. D. Wagner
The role of platelet adhesion receptor GPIb{alpha} far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis
PNAS, November 7, 2006; 103(45): 16900 - 16905.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. F. Mosher
Plasma Fibronectin Concentration: A Risk Factor for Arterial Thrombosis?
Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1193 - 1195.
[Full Text] [PDF]